title: Control of vancomycin-resistant enterococcus in health care facilities in a region.
abstract: BACKGROUND
  In late 1996, vancomycin-resistant enterococci were first detected in the Siouxland region of Iowa, Nebraska, and South Dakota. A task force was created, and in 1997 the assistance of the Centers for Disease Control and Prevention was sought in assessing the prevalence of vancomycin-resistant enterococci in the region's facilities and implementing recommendations for screening, infection control, and education at all 32 health care facilities in the region.
  
  
  METHODS
  The infection-control intervention was evaluated in October 1998 and October 1999. We performed point-prevalence surveys, conducted a case-control study of gastrointestinal colonization with vancomycin-resistant enterococci, and compared infection-control practices and screening policies for vancomycin-resistant enterococci at the acute care and long-term care facilities in the Siouxland region.
  
  
  RESULTS
  Perianal-swab samples were obtained from 1954 of 2196 eligible patients (89 percent) in 1998 and 1820 of 2049 eligible patients (89 percent) in 1999. The overall prevalence of vancomycin-resistant enterococci at 30 facilities that participated in all three years of the study decreased from 2.2 percent in 1997 to 1.4 percent in 1998 and to 0.5 percent in 1999 (P<0.001 by chi-square test for trend). The number of facilities that had had at least one patient with vancomycin-resistant enterococci declined from 15 in 1997 to 10 in 1998 to only 5 in 1999. At both acute care and long-term care facilities, the risk factors for colonization with vancomycin-resistant enterococci were prior hospitalization and treatment with antimicrobial agents. Most of the long-term care facilities screened for vancomycin-resistant enterococci (26 of 28 in 1998 [93 percent] and 23 of 25 in 1999 [92 percent]) and had infection-control policies to prevent the transmission of vancomycin-resistant enterococci (22 of 25 [88 percent] in 1999). All four acute care facilities had screening and infection-control policies for vancomycin-resistant enterococci in 1998 and 1999.
  
  
  CONCLUSIONS
  An active infection-control intervention, which includes the obtaining of surveillance cultures and the isolation of infected patients, can reduce or eliminate the transmission of vancomycin-resistant enterococci in the health care facilities of a region.
authors.affiliation: Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA. bostrow@hsc.vcu.edu
authors.forename: B E
authors.initials: BE
authors.lastname: Ostrowsky
authors.forename: W E
authors.initials: WE
authors.lastname: Trick
authors.forename: A H
authors.initials: AH
authors.lastname: Sohn
authors.forename: S B
authors.initials: SB
authors.lastname: Quirk
authors.forename: S
authors.initials: S
authors.lastname: Holt
authors.forename: L A
authors.initials: LA
authors.lastname: Carson
authors.forename: B C
authors.initials: BC
authors.lastname: Hill
authors.forename: M J
authors.initials: MJ
authors.lastname: Arduino
authors.forename: M J
authors.initials: MJ
authors.lastname: Kuehnert
authors.forename: W R
authors.initials: WR
authors.lastname: Jarvis
mesh_terms: D000328:Adult; D001003:Anal Canal / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D015169:Colony Count, Microbial; D004064:Digestive System / Q000382:microbiology; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D016984:Enterococcus faecium / Q000187:drug effects / Q000302:isolation & purification*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D006268:Health Facilities; D006306:Health Surveys; D006801:Humans; D017053:Infection Control / Q000379:methods*; D015146:Midwestern United States / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents